Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-01-04

Clinical Trial Update: Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial update suggests that acarbose combined with alcohol may lead to additional glucose lowering and anti-inflammatory effects in individuals with i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acarbose (acarbose)

Snippet

Sponsor: Taichung Veterans General Hospital | Conditions: Diabetes Mellitus, Impaired Glucose Tolerance | NA | Status: UNKNOWN